Cancer Alliance of Nebraska — Omaha, Nebraska

Cancer Alliance of Nebraska is a clinical research site located in Omaha, Nebraska, United States 68106.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Cancer Alliance of Nebraska has participated in 12 clinical trials with 5 currently active.

Therapeutic areas: Breast Cancer, Breast Adenocarcinoma, Hormone Receptor Positive.

Sponsors: Eli Lilly and Company, National Cancer Institute (NCI), Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Alliance of Nebraska?

Cancer Alliance of Nebraska has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Alliance of Nebraska conducted?

Cancer Alliance of Nebraska has 12 clinical trials on record, with 5 currently active. Their work covers Breast Cancer, Breast Adenocarcinoma, Hormone Receptor Positive.

Is Cancer Alliance of Nebraska accredited by Crixeo Health?

Cancer Alliance of Nebraska has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer Alliance of Nebraska?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.